AIM: The objective of this study was to evaluate the efficacy of diabetic macular edema (DME) therapy using subthreshold micropulse laser (SMPL) with a wavelength of 577 nm during a long-term monitoring period of 5 years. METHODS: The cohort included the total number of 52 eyes of 34 patients with DME. All underwent the standard laser treatment for the diabetic retinopathy outside the macula and DME treatment with SMPL. Subsequent check-ups were followed every 3 months in the first year of treatment, and every 4 to 6 months in the following years. The treatment was combined neither with focal macular laser nor with anti-VEGF therapy. RESULTS: The mean central retinal thickness (CRT) was 345.9 µm SD 122.6 µm at the beginning of the monitoring. At the end of the follow-up period five years after treatment it was 256.4 µm SD 98.4 µm. The mean CRT decreased by 89.5 µm SD 153.6 µm during 5 years. At the beginning of the monitoring, before treatment with SMPL, the best corrected visual acuity (BCVA) was 70.0, SD 10.1 ETDRS letters. One year after therapy, BCVA was 72, SD 10.0 letters, two years later it was 71.4, SD 10.4 letters and decreased to 66.9, SD 12.1 letters after 5 years. The mean BCVA decreased by merely 3.1, SD 10.9 letters during 5 years. CONCLUSION: Based on our long-term observations, the DME treatment with SMPL appears to be an effective method for reducing DME and protecting BCVA against rapid worsening.

Department of Medical Biophysics Faculty of Medicine in Hradec Kralove Charles University Hradec Kralove Czech Republic

Department of Ophthalmology Faculty of Health Studies Jan Evangelista Purkyne University and Department of Ophthalmology Masaryk Hospital Usti nad Labem Krajska zdravotni a s Usti nad Labem Czech Republic

Department of Ophthalmology Faculty of Medicine in Hradec Kralove Charles University and Department of Ophthalmology University Hospital Hradec Kralove Czech Republic

Zobrazit více v PubMed

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9thedition. Diabetes Res Clin Pract 2019;157:107843-52. [Epub ahead of print] doi: 10.1016/j.diabres.2019.107843 PubMed DOI

Chen E, Looman M, Laouri M, Gallagher M, Van Nuys K, Lakdawalla D, Fortuny J. Burden of illness of diabetic macular edema: literature review. Curr Med Res Opin 2010;26(7):1587-97. PubMed DOI

Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985;103:1796-806.

Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5):766-785.

Chhablani J, Roh YJ, Jobling AI, Fletcher EL, Lek JJ, Bansal P, Guymer R, Luttrull JK. Restorative retinal laser therapy: Present state and future directions. Surv Ophthalmol 2018;63(3):307-28. doi: 10.1016/j.survophthal.2017.09.008 PubMed DOI

Gawęcki M. Micropulse Laser Treatment of Retinal Diseases. J Clin Med 2019;8(2):242. doi: 10.3390/jcm8020242 PubMed DOI

Wu Y, Ai P, Ai Z, Xu G. Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti-VEGF therapy for diabetic macular edema: A Bayesian network meta-analysis. Biomed Pharmacother 2018;97:293-99. doi: 10.1016/j.biopha.2017.10.078 PubMed DOI

Kodjikian L, Bellocq D, Bandello F, Loewenstein A, Chakravarthy U, Koh A, Augustin A, de Smet MD, Chhablani J, Tufail A, García-Layana A, Sudhalkar A, Mathis T. First-line treatment algorithm and guidelines in center-involving diabetic macular edema. Eur J Ophthalmol 2019;29(6):573-84. doi: 10.1177/1120672119857511 PubMed DOI

Luttrull JK, Dorin G. Subtreshold Diode Micropulse Laser Photocoagulation (SMD) as Invisible Retinal Phototherapy for Diabetic Macular Edema. A Review, Current Diabetes Reviews 2012;8:274-84. PubMed DOI

Vujosevic S, Toma C, Villani E, Brambilla M, Torti E, Leporati F, Muraca A, Nucci P, De Cilla S. Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers. Transl Vis Sci Technol 2020;9(10):31. doi: 10.1167/tvst.9.10.31 PubMed DOI

Midena E, Micera A, Frizziero L, Pilotto E, Esposito G, Bini S. Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema. Sci Rep 2019;9(1):10034. doi: 10.1038/s41598-019-46515-y PubMed DOI

Hirabayashi K, Kakihara S, Tanaka M, Shindo T, Murata T. Investigation of the therapeutic mechanism of subthreshold micropulse laser irradiation in retina. Graefes Arch Clin Exp Ophthalmol 2020;258(5):1039-47. doi: 10.1007/s00417-020-04638-3 PubMed DOI

Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O'Neal DN, Januszewski AS. Biomarkers in Diabetic Retinopathy. Rev Diabet Stud 2015;12(1-2):159-95. doi: 10.1900/RDS.2015.12.159 PubMed DOI

Richter J, Zavorkova M, Vetvicka V, Liehneova I, Kral V, Rajnohova Dobiasova L. Effects of β-glucan and Vitamin D Supplementation on Inflammatory Parameters in Patients with Diabetic Retinopathy. J Diet Suppl 2019;16(4):369-78. doi: 10.1080/19390211.2018.1458769 PubMed DOI

Richter J, Pohorska J, Zavorkova M, Kral V, Stiborová I, Rajnohova Dobiasova L, Vetvicka V. Concentration of NK cells after β-glucan and vitamin D supplementation in patients with diabetic retinopathy. Folia Microbiol (Praha) 2020;65(4):755-61. doi: 10.1007/s12223-020-00789-2 PubMed DOI

Vujosevic S, Martini F, Longhin E, Convento E, Cavarzeran F, Midena E. Subtreshold micropulse yellow laser versus subtreshold micropulse infrared laser in center-involving diabetic macular edema. Retina 2015;35(8),1594-603. doi: 10.1097/IAE.0000000000000521 PubMed DOI

Yu AK, Merrill KD, Truong SN, Forward KM, Morse LS, Telander DG. The comparative histologic effects of subthreshold 532- and 810-nm diode micropulse laser on the retina. Invest Ophthalmol Vis Sci 2013;54(3):2216-24. PubMed DOI

Scholz P, Altay L, Fauser S. A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders. Adv Ther 2017;34(7):1528-55. doi: 10.1007/s12325-017-0559-y PubMed DOI

Chong V. Sublimital® treatment procedure. [cited 2022 Jun 6]. Available from: https://www.subliminal-laser-therapy.com/subliminal-laser-therapy-a-macular-treatment/

Lavinsky D, Cardillo JA, Melo LA Jr, Dare A, Farah ME, Belfort R Jr. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Invest Ophthalmol Vis Sci 2011;52(7):4314-23. PubMed DOI

Donati MC, Murro V, Mucciolo DP, Giorgio D, Cinotti G, Virgili G, Rizzo S. Subthreshold yellow micropulse laser for treatment of diabetic macular edema: Comparison between fixed and variable treatment regimen. Eur J Ophthalmo 2021;31(3):1254-60. doi: 10.1177/1120672120915169 PubMed DOI

Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E. Microperimetry and fundus autifluorescence in diabetic macular edema. Retina 2010;30(6):908-16. PubMed DOI

Luttrull JK, Sinclair SH. Safety of transfoveal subthreshold diode micropulse laser for fovea-involving diabetic macular edema in eyes with good visual acuity. Retina 2014;34(10):2010-20. doi: 10.1097/IAE.0000000000000177 PubMed DOI

Vesela S, Hejsek L, Stepanov A, Dusova J, Marak J, Jiraskova N, Studnicka J. The use of micropulse laser in patients with diabetic macular edema at the Department of Ophthalmology, Faculty Hospital Hradec Králové. Cesk Slov Oftalmol 2018;74(2):53-8. English. doi: 10.31348/2018/1/2-2-2018 PubMed DOI

Akkaya S, Açikalin B, Doğan YE, Çoban F. Subthreshold micropulse laser versus intravitreal anti-VEGF for diabetic macular edema patients with relatively better visual acuity. Int J Ophthalmol 2020;13(10):1606-11. doi: 10.18240/ijo.2020.10.15 PubMed DOI

Moisseiev E, Abbassi S, Thinda S, Yoon J, Yiu G, Morse LS. Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema. Eur J Ophthalmol 2018;28(1):68-73. doi: 10.5301/ejo.5001000 PubMed DOI

Abouhussein MA, Gomaa AR. Aflibercept plus micropulse laser versus aflibercept monotherapy for diabetic macular edema: 1-year results of a randomized clinical trial. Int Ophthalmol 2020;40:1147-54. doi: 10.1007/s10792-019-01280-9 PubMed DOI